David Stone 3/19/22 David Stone 3/19/22 Growth Stocks are Back on the Menu as Fears of WW3 Fade Read More David Stone 2/6/21 David Stone 2/6/21 Market Thoughts - Feb 6 – Gilead Jumps but Remains Criminally Undervalued Read More David Stone 1/30/21 David Stone 1/30/21 Market Thoughts - Jan 30 – Gilead and Pinging the Bid Read More David Stone 1/23/21 David Stone 1/23/21 Market Thoughts - Jan 23 - Gilead and Inhaled Remdesivir Read More David Stone 1/16/21 David Stone 1/16/21 Market Thoughts - 01-16-21 Read More David Stone 1/10/21 David Stone 1/10/21 Market Thoughts - 01-10-21 Read More
David Stone 3/19/22 David Stone 3/19/22 Growth Stocks are Back on the Menu as Fears of WW3 Fade Read More
David Stone 2/6/21 David Stone 2/6/21 Market Thoughts - Feb 6 – Gilead Jumps but Remains Criminally Undervalued Read More
David Stone 1/30/21 David Stone 1/30/21 Market Thoughts - Jan 30 – Gilead and Pinging the Bid Read More
David Stone 1/23/21 David Stone 1/23/21 Market Thoughts - Jan 23 - Gilead and Inhaled Remdesivir Read More